AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

NCT06063850 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Mesial Temporal Lobe Epilepsy

Interventions

GENETIC: AAV9-hSyn1-miGRIK2

Sponsor

UniQure Biopharma B.V.